CASP9 and esophageal squamous cell carcinoma: Moreover, treatment with cisplatin was proven to cause the activation of CAPN1 and CAPN2 upstream of BAX/BAK cleavage, leading to activation of caspase-9/3, which in turn resulted in GSDME-dependent pyroptosis in ESCC cells 252.